Fisher Asset Management
KURA icon

Fisher Asset Management’s Kura Oncology KURA Stock Holding History

Fisher Asset Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.87M Sell
625,936
-49,369
-7% -$466K ﹤0.01% 443
2026
Q1 		$5.49M Buy
675,305
+203,312
+43% +$1.75M ﹤0.01% 458
2025
Q4 		$4.9M Buy
+471,993
New +$4.95M ﹤0.01% 467

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Fisher Asset Management's KURA Position: Q2 2026 in Review

Fisher Asset Management reduced its Kura Oncology (KURA) stake by 7.3% in Q2 2026, selling an estimated $466K and leaving 625,936 shares worth $6.87M. The position accounts for ﹤0.01% of the portfolio, ranked #443.

Fisher Asset Management first reported a position in KURA in Q4 2025 and has held it in 3 quarters since. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Fisher Asset Management held 625,936 shares of Kura Oncology worth $6.87M as of Q2 2026.
  • Fisher Asset Management sold 49,369 Kura Oncology shares in Q2 2026, an estimated $466K.
  • Kura Oncology made up ﹤0.01% of Fisher Asset Management's portfolio in Q2 2026, its #443 holding.
  • Fisher Asset Management first reported a position in Kura Oncology in Q4 2025 and has held it in 3 quarters since.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Fisher Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.